TAM
HRTX icon

THB Asset Management’s Heron Therapeutics HRTX Stock Holding History

THB Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-296,320
Closed -$2.98M – 251
2014
Q4 		$2.98M Sell
296,320
-3,800
-1% -$31K 0.2% 160
2014
Q3 		$2.5M Buy
300,120
+19,302
+7% +$180K 0.17% 169
2014
Q2 		$3.46M Buy
280,818
+98,873
+54% +$1.18M 0.22% 158
2014
Q1 		$2.53M Buy
+181,945
New +$2.43M 0.15% 187

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

THB Asset Management's HRTX Position: Q1 2015 in Review

THB Asset Management sold out of Heron Therapeutics (HRTX) in Q1 2015, closing a stake of 296,320 shares — an estimated $2.98M sold.

THB Asset Management first reported a position in HRTX in Q1 2014 and held it in 4 quarters. The position peaked at $3.46M in Q2 2014. 69 funds tracked by Wall St. Rank hold HRTX as of Q1 2015.

  • THB Asset Management reported no remaining Heron Therapeutics position as of Q1 2015 after selling out during the quarter.
  • THB Asset Management sold 296,320 Heron Therapeutics shares in Q1 2015, an estimated $2.98M.
  • THB Asset Management first reported a position in Heron Therapeutics in Q1 2014 and held it in 4 quarters.
  • THB Asset Management's Heron Therapeutics position peaked at $3.46M in Q2 2014.
  • 69 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2015.

Based on THB Asset Management's 13F filing for Q1 2015, filed 24 Apr 2015.